Biomarkers are the foundation upon which successful precision medicine treatments can be built. Personalized drug discovery and development aim to improve clinical outcomes by delivering the right treatment to the right patient. This is particularly true for immunotherapy, in which characterization of tumor heterogeneity is essential for choosing the most effective therapy. Optimized treatment requires biomarkers that are both specific and sensitive. However, very few biomarkers have been translated into clinical diagnostics for patient care. In this roundtable discussion, we will discuss how precision medicine has changed the way we approach cancer and its treatment, and also look at how researchers can better combine diagnostic development with therapeutic strategies to provide more effective treatments.
During the webinar, the panelists will discuss:
- Current advances and trends in biomarker discovery
- Challenges and opportunities in combining the latest diagnostic techniques with current therapeutic regimens
- Future directions for biomarker discovery and application in precision medicine.
Viewers can ask questions live during the broadcast!
This webinar will last approximately 60 minutes.